A practical reference on regulatory status: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-07-18 and is reviewed periodically as new material appears.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
According to a 2009 leaked US Embassy cable, Houthis have reportedly established courts and prisons in areas they control. They impose their own laws on local residents, demand protection money, and dispense rough justice by ordering executions. AP's reporter, Ahmad al-Haj argued that the Houthis were winning hearts and minds by providing security in areas long neglected by the Yemeni government while limiting the arbitrary and abusive power of influential sheikhs. According to the Civic Democratic Foundation, Houthis help resolve conflicts between tribes and reduce the number of revenge killings in areas they control. The US ambassador believed that the reports that explain Houthi role as arbitrating local disputes were likely.
==== Cancer therapeutics ==== In 2022, over 1.9 million new cancer cases are projected in the U.S. alone. Nanogels are an attractive drug delivery solution for increasing both the efficacy of cancer therapeutics and their localization to cancer cells. Nanogels are currently being investigated for the treatment of different types of cancer, of which a few examples are listed here. In one study, chitosan-based nanogels loaded with doxorubicin, a chemotherapeutic, with a positive surface charge demonstrated a lower colorectal cancer cell viability compared to control groups and a similarly loaded nanogel with a negative surface charge. Another group conjugated folic acid to nanogels loaded with cisplatin or doxorubicin and delivered these therapeutics to ovarian cancer cells, which overexpress the folate receptor that binds with folic acid. These conjugated nanogels produced a significant decrease in tumor growth in a mouse model compared to vehicle controls and showed a site-specific delivery model for nanogels that may be effective for other types of cancer with upregulated folate receptors. Interestingly, gelatin-based nanogels loaded with cisplatin and conjugated to epidermal growth factor receptor (EGFR) ligands have been reported to successfully target lung cancer cells both in vitro and in vivo, with additional work confirming the effectiveness of these nanogels when transformed into aerosol particles.
== Other == Barbie—Barbie represented the American way of life, because she was the ultimate consumer. New Math was a strong reaction to the launch of Sputnik, by changing the way mathematics was taught to school age children. The Kitchen Debate was an impromptu debate (through interpreters) between Vice President Richard Nixon and Soviet Premier Nikita Khrushchev at the opening of the American National Exhibition in Moscow, on July 24, 1959.
Trump also signed the One Big Beautiful Bill Act into law, which permanently extended the tax cuts introduced in the first Trump administration, while increasing the deficit by around $3 trillion by 2034. Trump has also overseen a series of tariff increases and pauses, which led to retaliatory tariffs from other countries and stock market volatility. In international affairs, Trump has further pursued an expansionist and aggressive foreign policy, including the greater use of military force. His administration increased support for Israel in the Gaza war, struck Houthi targets in Yemen from March to May 2025 and aided Israel in the June 2025 Twelve-Day War, during which he carried out strikes on Iranian nuclear sites. In early October 2025, Trump's plan for a Gaza ceasefire deal between Israel and Hamas was signed. Trump has authorized a series of strikes on suspected drug traffickers in the Caribbean Sea, the legality of which is widely disputed under both U.S. and international law, and subsequently ordered a military intervention to overthrow and capture Nicolás Maduro, the disputed president of Venezuela, alleging that the Maduro government had links to narco-terrorist networks and conspired to flood the United States with cocaine. In February 2026, he launched a major attack on Iran with Israel with the stated goal of regime change, including the assassination of the Supreme Leader of Iran Ali Khamenei, which led to the 2026 Strait of Hormuz crisis and fuel crisis. As in his first presidency, Trump initiated the withdrawal of the U.S.
==== Glaxo ==== Joseph Nathan and Co. was founded in 1873, as a general trading company in Wellington, New Zealand, by a Londoner, Joseph Edward Nathan. In 1904, it began producing a dried-milk baby food from excess milk produced on dairy farms near Bunnythorpe. The resulting product was first known as Defiance, then as Glaxo (cf. Greek galaxias, "milky"), and was sold with the slogan "Glaxo builds bonnie babies." The Glaxo Laboratories sign is still visible on what is now a car repair shop on the main street of Bunnythorpe. The company's first pharmaceutical product, released in 1924, was vitamin D.
Sources: en.wikipedia.org
====== LAESI ====== In Laser ablation electrospray ionization (LAESI), a laser is used to ablate the surface of the sample and the emitted molecules are ionized in the gas phase by charged droplets from electrospray. Similar to DESI the ionization happens in ambient conditions. Anderton et al. used this ionization technique coupled to a Fourier transform mass spectrometer to analyze 200 single cells of Allium cepa (red onion) with high spatial resolution.
=== Compressor === Compressor refrigerators are by far the most common type; they make a noticeable noise, but are most efficient and give greatest cooling effect. Portable compressor refrigerators for recreational vehicle (RV) and camping use are expensive but effective and reliable. Refrigeration units for commercial and industrial applications can be made in various sizes, shapes and styles to fit customer needs. Commercial and industrial refrigerators may have their compressors located away from the cabinet (similar to split system air conditioners) to reduce noise nuisance and reduce the load on air conditioning in hot weather.
Raisins – are dried grapes produced in many regions of the world, and may be eaten raw or used in cooking, baking, and brewing. A ristra – is an arrangement of drying chili pepper pods, used to dry them and also for decoration.
==== Polymers ==== Electronic components that require clear transparency for light to exit or enter (photovoltaic panels and sensors) can be potted using acrylic resins that are cured using UV energy. The advantages are low VOC emissions and rapid curing.
=== Psychological === Autism: Oxytocin has been implicated in the etiology of autism, with one report suggesting autism is correlated to a mutation on the oxytocin receptor gene (OXTR). Studies involving Caucasian, Finnish and Chinese Han families provide support for the relationship of OXTR with autism. Autism may also be associated with an aberrant methylation of OXTR. However, evidence has shown that intranasal administration is likely insufficient to produce behavioural effects and it could be explained by publication bias and selective outcome reporting, impacting reproducibility of results. In addition, with focus being primarily on animal models that lack translational validity due to autism's complex social and communicative dimensions, current discussion has challenged the intervention and stated that neurodivergent perspectives need to be considered. Protection of brain functions: Studies in rats have demonstrated that nasal application of oxytocin can alleviate impaired learning capabilities caused by restrained stress. The authors attributed this effect to an improved hippocampal response in Brain-Derived Neurotrophic Factor (BDNF) being observed. Accordingly, oxytocin has been shown to promote neural growth in the hippocampus in rats even during swim stress or glucocorticoid administration. In a mouse model of early onset of Alzheimer's, the administration of oxytocin by a gel particularly designed to make the peptide accessible for the brain, the cognitive decline and hippocampal atrophy of these mice were delayed.
Sources: en.wikipedia.org
PLGA is typically synthesized by ring-opening polymerization of the cyclic dimers lactide and glycolide, a method widely used because it allows better control over molecular weight and copolymer composition than direct condensation methods. Other reports show direct polycondensation of lactic acid and glycolic acid as another method, but this approach gives lower molecular weight material and is less suitable for producing controlled, high-performance PLGA grades. Common catalysts include tin(II) 2-ethylhexanoate and related organometallic catalysts, which are widely used in melt polymerization because of their activity and practical availability.
These physiological changes in the decomposers also alter the local environment in a way that allows certain minerals to be deposited, while others remain in solution. Generally, however, a fossilizing egg's shell keeps the same calcite it had in life, which allows scientists to study its original structure millions of years after the developing dinosaur hatched or died. However, eggs can also sometimes be altered after burial. This process is called diagenesis. One form of diagenesis is a microscopic cross-hatched pattern imposed on the eggshell by the pressure of being buried deeply. If the pressure gets severe enough, sometimes the eggshell's internal microscopic structure can be completely destroyed. Diagenesis can also happen chemically in addition to physically. The chemical conditions of a decomposing egg can make it easy for silica to be incorporated into eggshell and damage its structure. When iron-bearing substances alter eggshell it can be obvious because compounds like hematite, pyrite, and iron sulfide can turn the shell blackish or rusty colors.
== Pharmacokinetics == The substance is absorbed quickly from the gut and reaches its maximum plasma concentration (Cmax) after about two hours. If applied rectally, Cmax is reached after four hours. The bioavailability of the suppositories, measured as area under the curve (AUC), is about twofold that of oral formulations, due to a first pass effect of over 50%. By far the most important metabolisation reaction is ester hydrolysis, which accounts for 26.3% of the total clearance through the kidneys. Only 0.37% are cleared in form of the original substance. The plasma half life is 2.3 hours for oral formulations and three to 3.5 hours for suppositories. Pentoxyverine is also excreted into the breast milk.
=== Mental health === TikTok has become a hub for mental health content, where users share personal experiences with depression and anxiety. While this has helped normalize conversations around mental health, it also raises concerns. Dr. Corey Basch, a public health professor, points out that TikTok's algorithm can create echo chambers. Users who engage with posts about anxiety or despair may find themselves bombarded with similar content, which can lead to a harmful cycle. This surge in mental health discussions has also contributed to more young people self-diagnosing conditions like ADHD and anxiety before consulting a professional. Researchers are concerned about the influence of profit-driven motives, with the platform promoting mental health apps and influencers sponsored by these companies. These services often advertise quick, quiz-based diagnoses, which may oversimplify complex issues. Additionally, misinformation is a growing problem; studies have found that some videos about therapies, like cognitive behavioral therapy, include inaccurate or misleading information.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.